Skip to content
Contact us

SIRION Biotech Opens a New Viral Vector Research and Manufacturing Center!

We are pleased to announce that we are expanding! Our new state-of-the-art laboratories will be officially opened on Thursday June 23.

SIRION Biotech’s success story began in 2006 in the Martinsried Innovation and Start-up Center Biotechnology (IZB), and continues now with its move into a new research and manufacturing center in Gräfelfing near Munich. This new location triples SIRION’s laboratory and office space dedicated to the company mission: creating optimized viral vectors and technologies that enable research organizations and cell and gene therapy companies to develop new therapies with increased patient safety and efficacy. 

“The global demand for high-quality viral vectors is increasing and the existing development capacities are limited, so tripling the capacity of SIRION Biotech in Graefelfing is attracting attention worldwide. We opened a new research laboratory in Heidelberg in 2020 and are planning something similar for Boston in early 2023,“ says Dr. Christian Thirion, CEO of SIRION Biotech.

To date, SIRION Biotech has developed more than 8,000 viral vectors for more than 600 cell and gene therapy developers worldwide. Its technologies are used in over 30 clinical programs in the US, Europe and China.

Key Information

  • SIRION Biotech delivers custom viral vectors for preclinical research and development to over 150 customers worldwide every year.

  • Key competencies relate to the engineering of viral vectors using bioinformatics and molecular design to enhance efficacy and safety. State of the art production, purification, and quality control processes have been developed through years of experience developing and producing more than 8000 vectors.

  • 3 floors of laboratories rated for S1 and S2 biosecurity; Basement currently for storage and future use for large scale bioreactors.

  • Capacity for growth: up to 4 times as many staff as currently.

  • Another location for sales, marketing and administration is located in nearby Martinsried, with an additional research laboratory located in Heidelberg. Sales offices are located in Paris and Boston. Currently 65 employees worldwide.

  • Technological development is supported by collaborations with key research organizations such as the Helmholtz Institute, Heidelberg University Clinic, Innsbruck University, and the Ludwig Maximilian University, the Technical University in Munich.

Subscribe Here!